Divi's Laboratories Ltd.'s consolidated net profit rose in the fourth quarter of fiscal 2024, beating analysts' estimates.
Net profit rose 68% year-on-year to Rs 538 crore in the quarter-ended March 31, 2024, as compared with Rs 321 crore in the year-ago period, according to an exchange filing. Analysts tracked by Bloomberg had estimated a profit of Rs 449.75 crore.
Divi's Laboratories Q4 FY24 Result Highlights (Consolidated, YoY)
Revenue up 18% to Rs 2,303 crore versus Rs 1,951 crore (Bloomberg estimate: Rs 2095.7 crore).
Ebitda up 50% to Rs 731 crore versus Rs 487 crore (Bloomberg estimate: Rs 607.5 crore).
Margin at 31.7% versus 25% (Bloomberg estimate: 29.00%).
Net profit up 68% at Rs 538 crore versus Rs 321 crore (Bloomberg estimate: Rs 449.8 crore).
Shares of company closed higher at 0.07% at Rs 4,116 apiece on the NSE, as compared with a 0.04% decline in the benchmark Nifty 50.